Chargement en cours...
Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro
Although thrombomodulin alfa (TM alfa), recombinant human soluble thrombomodulin, exerts antithrombogenic effects through activated protein C (APC), clinical trials suggested that TM alfa has a lower bleeding risk than does recombinant human APC. To address the mechanism explaining this difference,...
Enregistré dans:
| Publié dans: | Clin Appl Thromb Hemost |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714727/ https://ncbi.nlm.nih.gov/pubmed/29683037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029618770274 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|